# BRENZAVVY

NDC: 82381-2174
Generic name: Bexagliflozin
Labeler / Manufacturer: TheracosBio, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20230713

FDA application: NDA214373

## Active ingredients

- BEXAGLIFLOZIN: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"82381-2174"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=82381-2174
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3cdf28fc-4194-4ad6-aa03-c9eaa68da83e